HIGHBRIDGE CAPITAL MANAGEMENT LLC

Position in APGE — Apogee Therapeutics, Inc.

CIK 919185 NEW YORK, NY

Position in APGE

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$20,686,899

New position

Shares Held

155,857

first reported quarter

Ownership

0.206%

of shares outstanding

% of Portfolio

1.23%

of 13F equity value

Holder Rank

#62

of 285 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Jun 30, 2026

HIGHBRIDGE CAPITAL MANAGEMENT LLC holds $22,154,220 across 5 Biotechnology names. APGE ranks #1 (93.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	APGE	Apogee Therapeutics, Inc. This page	155,857	$20,686,899
2	SLS	SELLAS Life Sciences Group, Inc.	99,400	$1,467,144
3	CLDI	Calidi Biotherapeutics, Inc.	65	$177
4	OSRH	OSR Health, Inc.	106,730	$0
5	ASBP	Aspire Biopharma Holdings, Inc.	94,792	$0

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$20,686,899	155,857	—	Shares	Sole	2026-08-14
No filing history on record for this holder in this stock.